Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off
09:29pm, Tuesday, 03'rd Feb 2026
Pfizer's stock has declined 40% over the past three years, as it has struggled to attract investors. Investors appear to be underrating its growth prospects, as the company has a robust pipeline.
Market Today: Disney picks D'Amaro; PepsiCo trims prices
05:35pm, Tuesday, 03'rd Feb 2026
Guru Stock PicksT Rowe Price Equity Income Fund has made the following transactions:Reduce in MET by 1.04%Sold out in ADBEAdd in REXR by 1.73%New position in CO
Pfizer Inc (PFE) Q4 2025 Earnings Call Highlights: Strategic Acquisitions and Revenue Guidance Amidst Operational Challenges
04:03pm, Tuesday, 03'rd Feb 2026
Full Year Revenue: $62.6 billion, a 2% operational decline from the previous year.Operational Revenue Growth (Excluding COVID-19 Products): 6% for the full yea
Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript
03:00pm, Tuesday, 03'rd Feb 2026
Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript
Pfizer: Messy Q4 Earnings Mask An Improving Business
02:02pm, Tuesday, 03'rd Feb 2026
Pfizer Inc. earns a Buy rating as the market overreacts to Q4's non-cash loss and conservative 2026 guidance, overlooking underlying operational strength. Excluding COVID-19 products, PFE posted 9% Yo
Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data
12:35pm, Tuesday, 03'rd Feb 2026
PFE shares fall even after Q4 earnings beat on COVID product declines and muted investor reaction to new obesity drug data.
Silver Surges Over 15%; Pfizer Earnings Top Views
12:00pm, Tuesday, 03'rd Feb 2026
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday.
Stock Market Today: Major Indexes Decline; Dow Sets New All-Time High Before Pulling Back; Gold, Silver Rebound
12:00pm, Tuesday, 03'rd Feb 2026
Major equities indexes fell Tuesday, although the Dow Jones Industrial Average hit a new all-time high before slipping. Meanwhile, gold and silver futures resumed their ascent.
Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever
11:56am, Tuesday, 03'rd Feb 2026
Pfizer reported Q4 and FY2025 revenues and EPS above expectations, but core revenues declined due to falling COVID product sales. Despite a 6.5% dividend yield and low valuation multiples, PFE remains
Why Is Pfizer Stock Sliding Today
11:30am, Tuesday, 03'rd Feb 2026
Pfizer (PFE) shares slid 3% after reporting a drop in fourth-quarter revenue, reflecting reduced demand for its Covid-19 vaccine and antiviral treatment.The pha
Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways
11:17am, Tuesday, 03'rd Feb 2026
Geoff Meacham, Citi Research head of U.S. pharmaceuticals and biotechnology, joins 'Squawk Box' to break down the quarterly earnings results of Pfizer and Merck.
Why Pfizer Stock Dropped Today
11:16am, Tuesday, 03'rd Feb 2026
Pfizer beat on 2025 sales and beat on earnings -- but still delivered a loss. Pfizer reaffirmed 2026 sales and earnings guidance for under $3 per share.
2 Pharma Stocks React to Quarterly Results, Guidance
11:04am, Tuesday, 03'rd Feb 2026
Pfizer Inc (NYSE:PFE) shares are down 3.2% to trade at $25.40 at last check, despite surpassing earnings and revenue expectations for the fourth quarter.
Pfizer Projects Revenue Dip in 2026 as Patent Losses Weigh
10:35am, Tuesday, 03'rd Feb 2026
Pfizer Inc. (PFE, Financials) is getting ready for a drop in sales in 2026. The company says it might lose $1.5 billion since several of its most important medi
Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31am, Tuesday, 03'rd Feb 2026
While the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
